Cargando…
EE410 Cost-Effectiveness Analysis of Remdesivir for the Treatment of COVID-19 Hospitalized Adults in Three Countries of LATAM: Argentina, Chile, and Colombia
Autores principales: | Montejano, R, Riera, F, Falistocco, C, Espinoza, L, Azamar-Alonso, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232716/ http://dx.doi.org/10.1016/j.jval.2022.04.658 |
Ejemplares similares
-
Implementation of a molecular tumour board in LATAM: the impact on treatment decisions for patients evaluated at Instituto Alexander Fleming, Argentina
por: Angel, Martín Osvaldo, et al.
Publicado: (2021) -
EE527 Cost-Effectiveness and Budget Impact Analysis of Remdesivir for the Treatment of COVID-19 in Greece
por: Athanasakis, K, et al.
Publicado: (2022) -
Cost-effectiveness of COVID-19 vaccination in Latin America and the Caribbean: an analysis in Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, and Peru
por: Augustovski, Federico, et al.
Publicado: (2023) -
Contributing factors for acute stress in healthcare workers caring for COVID-19 patients in Argentina, Chile, Colombia, and Ecuador
por: Martin-Delgado, Jimmy, et al.
Publicado: (2022) -
Lung Transplantation during COVID19 Pandemic: Latam Experience
por: Bertolotti, A.M., et al.
Publicado: (2021)